GLP-1 is an enteric insulin-secreting molecule used in the treatment of T2DM because of its properties, such as causing central appetite suppression, protection of pancreatic islet β-cells, and cardiovascular protective effects [47]. This evidence concerns the gene INS and type 2 diabetes mellitus.